Dialogues: A conversation with Themrise Khan

Dialogues: A conversation with Themrise Khan

Up next

Ability in disability from noma: neglected tropical diseases part 1

This two-part episode shines a light on the lived experiences of two remarkable individuals affected by NTDs. We explore firsthand how disability influences and affects their lives. In part 1, host <a href='https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Ftwit ...

  Show more

From disability to advocacy for leprosy: neglected tropical diseases part 2

This two-part episode shines a light on the lived experiences of two remarkable individuals affected by NTDs. We explore firsthand how disability influences and affects thei ...

  Show more

Recommended Episodes

Introduction to Global Health
The Rx Bricks Podcast

<h2 id="header-9c83a0c4947a4ff482f264ddb56bfda5" class="brick-header brick-header-primary markup-enabled medium-editor-element" role="textbox" data-rxannotationdata="content.text" data-medium-editor-element="true" aria-multiline="true" data-medium-editor-editor-index="1" data-pla ...  Show more

Let's Diagnose Global Health Today | Dr Slim Slama
The afikra Podcast

The CEO of the World Innovation Summit for Health (WISH), Dr Slim Slama, joins us on this episode of The afikra Podcast to give an in-depth look into the complexities and challenges facing global health today, including the rise of non-communicable diseases, the impact of urba ...

  Show more

Youth skills in a rapidly changing world
Our World, Connected

Meet Dr John Mugo and Beria Wawira – two colleagues on a mission to empower millions of young people and parents through the Zizi Afrique Foundation in Kenya. In conversation with host Christine Wilson, they ask: are we preparing young people for success in today’s fast-paced ...

  Show more

#22 Reforming pharmacovigilance education – Michael Reumerman
Drug Safety Matters

Healthcare professionals are key players in medicines safety but they often lack the time or knowledge to report adverse drug reactions. To change that, we need to urgently rethink how we teach pharmacovigilance, argues Michael Reumerman from Amsterdam University Medical Cente ...

  Show more